Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Transcranial sonography in Parkinson's disease.

Bor-Seng-Shu E, Pedroso JL, Andrade DC, Barsottini OG, Andrade LA, Barbosa ER, Teixeira MJ.

Einstein (Sao Paulo). 2012 Apr-Jun;10(2):242-6. Review. English, Portuguese.

2.

Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.

Iranzo A, Stockner H, Serradell M, Seppi K, Valldeoriola F, Frauscher B, Molinuevo JL, Vilaseca I, Mitterling T, Gaig C, Vilas D, Santamaria J, Högl B, Tolosa E, Poewe W.

Mov Disord. 2014 Dec;29(14):1774-80. doi: 10.1002/mds.26055. Epub 2014 Nov 10.

PMID:
25384461
3.

[Transcranial sonography of substantia nigra in patients with Parkinson's disease].

Miwa H.

Rinsho Shinkeigaku. 2013;53(11):981-2. Review. Japanese.

PMID:
24291852
4.

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography.

Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K.

Neurology. 1995 Jan;45(1):182-4.

PMID:
7824114
5.

Hyperechogenicity of the substantia nigra in Parkinson's disease.

Ressner P, Skoloudík D, Hlustík P, Kanovský P.

J Neuroimaging. 2007 Apr;17(2):164-7.

PMID:
17441838
6.

[Transcranial sonography in Parkinson's disease].

Fedotova EIu, Chechetkin AO, Shadrina MI, Slominskiĭ PA, Ivanova-Smolenskaia IA, Illarioshkin SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(1):49-55. Russian.

PMID:
21350412
7.

No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.

Lobsien E, Schreiner S, Plotkin M, Kupsch A, Schreiber SJ, Doepp F.

Mov Disord. 2012 Mar;27(3):450-3. doi: 10.1002/mds.24070. Epub 2012 Jan 11.

PMID:
22237792
8.

[Usefulness of transcranial sonography in Parkinson's disease. A comparative study using 123I-FP-CIT SPECT].

Hernández Vara J, Rubiera del Fueyo M, Lorenzo Bosquet C, Castell Conesa J, Molina Cateriano CA, Rodríguez FM.

Med Clin (Barc). 2008 Sep 13;131(8):285-9. Spanish.

PMID:
18803921
9.

Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.

Sprenger FS, Wurster I, Seppi K, Stockner H, Scherfler C, Sojer M, Schmidauer C, Berg D, Poewe W.

Mov Disord. 2016 Apr;31(4):579-83. doi: 10.1002/mds.26515. Epub 2016 Feb 19.

PMID:
26893155
10.

Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.

Zhou HY, Sun Q, Tan YY, Hu YY, Zhan WW, Li DH, Wang Y, Xiao Q, Liu J, Chen SD.

Parkinsonism Relat Disord. 2016 Mar;24:28-33. doi: 10.1016/j.parkreldis.2016.01.021. Epub 2016 Jan 26.

PMID:
26842545
11.

[Transcranial sonography for the diagnosis of Parkinson disease].

Venegas F P, Miranda G G, Silva C MC.

Rev Med Chil. 2011 Jan;139(1):54-9. doi: /S0034-98872011000100007. Epub 2011 Apr 11. Spanish.

12.

Substantia nigra hyperechogenicity in Parkinson's disease.

Bor-Seng-Shu E, Fonoff ET, Barbosa ER, Teixeira MJ.

Acta Neurochir (Wien). 2010 Dec;152(12):2085-7. doi: 10.1007/s00701-010-0736-0. Epub 2010 Jul 11. Review. No abstract available.

PMID:
20623147
13.

Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.

Walter U, Wittstock M, Benecke R, Dressler D.

J Neural Transm (Vienna). 2002 Feb;109(2):191-6.

PMID:
12075859
14.

Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R.

Brain. 2007 Jul;130(Pt 7):1799-807. Epub 2007 Feb 28.

PMID:
17329323
15.

[Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].

Mijajlović M, Petrović I, Stojković T, Svetel M, Stefanova E, Kostić VS.

Vojnosanit Pregl. 2008 Aug;65(8):601-5. Serbian.

PMID:
18751340
16.

Transcranial sonography in the early and differential diagnosis of Parkinson's disease.

Berg D.

J Neural Transm Suppl. 2006;(70):249-54. Review.

PMID:
17017537
17.

Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.

Pedroso JL, Bor-Seng-Shu E, Felicio AC, Braga-Neto P, Dutra LA, de Aquino CC, Ferraz HB, do Prado GF, Teixeira MJ, Barsottini OG.

J Neurol Sci. 2012 Aug 15;319(1-2):59-62. doi: 10.1016/j.jns.2012.05.015. Epub 2012 May 24.

PMID:
22632781
18.

Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Berg D.

J Neural Transm (Vienna). 2011 Mar;118(3):453-61. doi: 10.1007/s00702-010-0469-5. Epub 2010 Sep 10. Review.

PMID:
20830493
19.

Pathophysiology of transcranial sonography signal changes in the human substantia nigra.

Double KL, Todd G, Duma SR.

Int Rev Neurobiol. 2010;90:107-20. doi: 10.1016/S0074-7742(10)90008-1. Review.

PMID:
20692497
20.

Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.

Ruprecht-Dörfler P, Berg D, Tucha O, Benz P, Meier-Meitinger M, Alders GL, Lange KW, Becker G.

Neuroimage. 2003 Feb;18(2):416-22.

PMID:
12595195

Supplemental Content

Support Center